Allergy Therapeutics has announced the presentation of data in a Satellite Symposium “Adjuvants in Allergy: elevating efficacy” at the 35th Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) in Vienna on 12 June 2016. The continued recognition of its innovative platforms further highlights Allergy Therapeutics’ leading role within the industry. We repeat our Conviction Buy.

13 Jun 2016
Panmure Morning Note 13-06-2016

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Panmure Morning Note 13-06-2016
Allergy Therapeutics plc (AGY:LON) | 8.2 0 (-3.5%) | Mkt Cap: 393.2m
- Published:
13 Jun 2016 -
Author:
Dr Mike Mitchell -
Pages:
3 -
Allergy Therapeutics has announced the presentation of data in a Satellite Symposium “Adjuvants in Allergy: elevating efficacy” at the 35th Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) in Vienna on 12 June 2016. The continued recognition of its innovative platforms further highlights Allergy Therapeutics’ leading role within the industry. We repeat our Conviction Buy.